Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: CELL THERAPEUTICS INC

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of CELL THERAPEUTICS INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of CELL THERAPEUTICS INC since year 2005. Table 2 shows the detailed insider transactions of CELL THERAPEUTICS INC since 2005. The reporting company's ticker symbol is CTIC. The reporting company's CIK number is 891293.

The total value of stock buying since 2005 is $156,506. The total value of stock sales is $1,170,688. The total value of stock exercises is $0.


1 year stock price chart,   1 day stock price chart
opopp
opopopop

Figure 1. Monthly insider transaction values at CELL THERAPEUTICS INC (CTIC) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • $206,985

    $20,698

    $2,069

    $206

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at CELL THERAPEUTICS INC (CTIC) in the past 24 months. See table 2 for insider transaction details.

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • $3.87

    $2.90

    $1.94

    $.97



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for CELL THERAPEUTICS INC (CTIC).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2008-03 202,900 110,506 0 0 0 0
2007-12 0 0 750 1,492 0 0
2007-08 0 0 625 2,418 0 0
2007-06 0 0 1,450 5,039 0 0
2007-03 0 0 105,740 168,704 0 0
2006-12 0 0 112,184 206,985 0 0
2006-09 0 0 75,000 146,235 0 0
2006-08 0 0 2,500 3,850 0 0
2006-06 0 0 42,000 59,491 0 0
2006-05 0 0 65,000 115,180 0 0
2006-03 0 0 1,500 2,940 0 0
2006-01 0 0 18,635 41,855 0 0
2005-12 0 0 59,250 138,507 0 0
2005-08 0 0 27,500 68,915 0 0
2005-07 0 0 16,825 45,427 0 0
2005-05 0 0 18,000 53,100 0 0
2005-04 0 0 30,000 110,550 0 0
2005-03 10,000 46,000 0 0 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for CELL THERAPEUTICS INC (CTIC)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-03-19 Bianco James A (President and CEO) Purchase 102,900 .52 53,508
2008-03-18 Bianco James A (President and CEO) Purchase 75,000 .57 42,749
2008-03-18 Nudelman Phillip M Phd (Director) Purchase 25,000 .57 14,249
2007-12-14 Bianco Louis A (EVP, Finance & Administration) Sale 750 1.99 1,492
2007-08-31 Stromatt Scott (EVP, Clinical Dev & Reg Affair) Sale 625 3.87 2,418
2007-06-14 Singer Jack W (EVP, Chief Medical Officer) Sale 700 3.47 2,429
2007-06-14 Bianco Louis A (EVP, Finance & Administration) Sale 750 3.48 2,610
2007-03-27 Bianco James A (President and CEO) Sale 35,000 1.60 56,000
2007-03-26 Bianco Louis A (EVP, Finance & Administration) Sale 30,000 1.58 47,520
2007-03-26 Bianco James A (President and CEO) Sale 40,740 1.60 65,184
2006-12-22 Stromatt Scott (EVP, Clinical Dev & Reg Affair) Sale 20,000 1.81 36,200
2006-12-14 Singer Jack W (EVP, Chief Medical Officer) Sale 2,625 1.86 4,882
2006-12-14 Bianco Louis A (EVP, Finance & Administration) Sale 7,500 1.86 13,950
2006-12-14 Bianco James A (President and CEO) Sale 37,893 1.80 68,169
2006-12-13 Singer Jack W (EVP, Chief Medical Officer) Sale 13,400 1.89 25,326
2006-12-13 Bianco Louis A (EVP, Finance & Administration) Sale 12,999 1.89 24,568
2006-12-13 Stromatt Scott (EVP, Clinical Dev & Reg Affair) Sale 7,500 1.89 14,178
2006-12-11 Singer Jack W (EVP, Chief Medical Officer) Sale 1,600 1.92 3,072
2006-12-11 Bianco Louis A (EVP, Finance & Administration) Sale 8,667 1.92 16,640
2006-09-29 Bianco James A (President and CEO) Sale 37,500 1.72 64,312
2006-09-18 Bianco James A (President and CEO) Sale 37,500 2.18 81,923
2006-08-30 Stromatt Scott (EVP, Clinical Dev & Reg Affair) Sale 2,500 1.54 3,850
2006-06-23 Brown Jade (EVP, Chief Business Officer) Sale 9,500 1.41 13,395
2006-06-21 Brown Jade (EVP, Chief Business Officer) Sale 12,500 1.46 18,196
2006-06-20 Stromatt Scott (EVP, Clinical Dev & Reg Affair) Sale 20,000 1.40 27,900
2006-05-08 Bianco James A (President and CEO) Sale 65,000 1.77 115,180
2006-03-31 Brown Jade (EVP, Chief Business Officer) Sale 1,500 1.96 2,940
2006-01-03 Bianco Louis A (Administration) Sale 4,000 2.25 9,000
2006-01-03 Bianco James A (President and CEO) Sale 14,635 2.24 32,855
2005-12-20 Stromatt Scott (Reg Affair) Sale 20,000 2.24 44,700
2005-12-12 Singer Jack W (EVP, Chief Medical O) Sale 7,583 2.39 18,123
2005-12-12 Bianco James A (President and CEO) Sale 25,000 2.39 59,750
2005-12-09 Bianco Louis A (Administration) Sale 6,667 2.39 15,934
2005-08-29 Stromatt Scott (Reg Affair) Sale 27,500 2.51 68,915
2005-07-01 Singer Jack W (EVP, Chief Medical O) Sale 3,200 2.70 8,640
2005-07-01 Bianco Louis A (Administration) Sale 4,000 2.70 10,800
2005-07-01 Bianco James A (President and CEO) Sale 9,625 2.70 25,987
2005-05-31 Bianco James A (President and CEO) Sale 18,000 2.95 53,100
2005-04-05 Bianco James A (President and CEO) Sale 30,000 3.68 110,550
2005-03-14 Fluke John M Jr (Director) Purchase 5,000 4.00 20,000
2005-03-10 Link Max (Director) Purchase 5,000 5.20 26,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of CELL THERAPEUTICS INC (symbol CTIC, CIK number 891293) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.